AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitason-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Unison Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitason-M 50/500 Tablet

Diabetac Duo 50/500 tablets combine two medications to effectively manage elevated blood glucose in type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risks. Diabetac Duo 50/500 may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly influence blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn how to identify and manage this. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or nursing individuals should seek medical advice prior to use. Interactions with other medications are possible; disclose all current medications to your doctor to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar throughout treatment.

Uses of Sitason-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitason-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Sitason-M 50/500 Tablet with a meal.

Common Side effects of Sitason-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitason-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Sitason-M 50/500 Tablet with a meal.

How Sitason-M 50/500 Tablet works:

Sitagliptin and metformin, combined as Sitason-M 50/500 tablets, offer enhanced blood sugar management. Sitagliptin boosts insulin production from the pancreas, improves the body's insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitason-M 50/500 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitason-M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitason-M 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitason-M 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Sitason-M 50/500 Tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from taking Sitason-M 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitason-M 50/500 Tablet :

Should you forget a dose of Sitason-M 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitason-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitason-M 50/500 Tablet

Sitason-M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitason-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, yearly supplemental vitamin B12 is recommended by some researchers.
Sitason-M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitason-M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitason-M 50/500 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitason-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitason-M and seek immediate medical attention.
Sitason-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitason-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitason-M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitason-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitason-M 50/500 Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitason-M immediately and seek medical attention.
Prolonged Sitason-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems or ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitason-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Sitason-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitason-M 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitason-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitason-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitason-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Sitason-M 50/500 Tablet
59